Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Senseonics Holdings, Inc.
Senseonics Holdings, Inc. News
Jul 16, 2025 - globenewswire.com
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
Jun 18, 2025 - zacks.com
Here's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 Weeks
Jun 4, 2025 - globenewswire.com
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
May 21, 2025 - globenewswire.com
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement
Senseonics Holdings, Inc. Quantitative Score
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Senseonics Holdings, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Senseonics Holdings, Inc. Financials
Table Compare
Compare SENS metrics with: | |||
|---|---|---|---|
Earnings & Growth | SENS | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | SENS | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | SENS | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | SENS | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Senseonics Holdings, Inc. Income
Senseonics Holdings, Inc. Balance Sheet
Senseonics Holdings, Inc. Cash Flow
Senseonics Holdings, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Senseonics Holdings, Inc. Executives
| Name | Role |
|---|---|
| Dr. Timothy T. Goodnow Ph.D. | President, Chief Executive Officer & Director |
| Dr. Mukul Jain Ph.D. | Chief Operating Officer |
| Mr. Kenneth L. Horton J.D. | General Counsel & Corporate Development Advisor |
| Dr. Francine Ratner Kaufman M.D. | Chief Medical Officer & Director |
| Mr. Frederick T. Sullivan CPA | Chief Financial Officer, Secretary & Treasurer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. Timothy T. Goodnow Ph.D. | President, Chief Executive Officer & Director | 1962 | 1.27M | |
| Dr. Mukul Jain Ph.D. | Chief Operating Officer | 1973 | 902.92K | |
| Mr. Kenneth L. Horton J.D. | General Counsel & Corporate Development Advisor | Male | 1967 | 750.71K |
| Dr. Francine Ratner Kaufman M.D. | Chief Medical Officer & Director | 1952 | -- | |
| Mr. Frederick T. Sullivan CPA | Chief Financial Officer, Secretary & Treasurer | Male | 1982 | -- |
Senseonics Holdings, Inc. Insider Trades
| Date | 1 Jul |
| Name | Prince Douglas S |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 17069 |
| Date | 1 Jul |
| Name | ROEDER DOUGLAS A |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 30987 |
| Date | 1 Jul |
| Name | Fiorentino Edward |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 29674 |
| Date | 1 Jul |
| Name | Steven Edelman |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 27048 |
| Date | 16 Jun |
| Name | Sullivan Frederick T. |
| Role | Chief Financial Officer |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 27263 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 1 Jul | Prince Douglas S | Director | Acquired | A-Award | 17069 |
| 1 Jul | ROEDER DOUGLAS A | Director | Acquired | A-Award | 30987 |
| 1 Jul | Fiorentino Edward | Director | Acquired | A-Award | 29674 |
| 1 Jul | Steven Edelman | Director | Acquired | A-Award | 27048 |
| 16 Jun | Sullivan Frederick T. | Chief Financial Officer | Disposed | F-InKind | 27263 |